Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies
Saved in:
| Published in: | Advances and Applications in Bioinformatics and Chemistry |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies
- In Silico Molecular Docking of Marine Drugs Against Cancer Proteins
- In Silico Molecular Docking Analysis of Natural Pyridoacridines as Anticancer Agents
- Retraction: Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets
- In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
- In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis
- Toward Understanding the Anticancer Activity of the Phytocompounds from Eugenia uniflora Using Molecular Docking, in silico Toxicity and Dynamics Studies